Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| January 18th, 2023 |
Grants for Injury Control Research Centers (ICRC) |
Centers for Disease Control and Prevention ERA |
| September 7th, 2023 |
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 3rd, 2024 |
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| October 3rd, 2024 |
Postdoctoral Research Associate Training (PRAT) Program (Fi2) |
National Institutes of Health |
| November 12th, 2025 |
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) |
National Institutes of Health |
| July 1st, 2025 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
National Institutes of Health |
| October 26th, 2022 |
Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 12th, 2025 |
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) |
National Institutes of Health |
| April 3rd, 2023 |
State Public Health Approaches to Addressing Arthritis |
Centers for Disease Control NCCDPHP |
| May 8th, 2023 |
Overdose Data to Action in States |
Centers for Disease Control NCIPC |
| November 21st, 2022 |
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) |
National Institutes of Health |
| November 21st, 2022 |
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) |
National Institutes of Health |
| February 2nd, 2023 |
HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional) |
National Institutes of Health |
| December 20th, 2022 |
Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 26th, 2022 |
Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 7th, 2022 |
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) |
National Institutes of Health |
| September 27th, 2022 |
HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required) |
National Institutes of Health |
| October 26th, 2023 |
Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
| September 11th, 2025 |
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| September 11th, 2025 |
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) |
National Institutes of Health |
|
| September 11th, 2025 |
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2023 |
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) |
National Institutes of Health |
| July 12th, 2023 |
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) |
National Institutes of Health |
| January 17th, 2023 |
Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) |
Centers for Disease Control and Prevention ERA |
| January 20th, 2023 |
Miner Safety and Health Training Program - Western United States |
Centers for Disease Control and Prevention ERA |
| September 27th, 2022 |
HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional) |
National Institutes of Health |
| December 5th, 2022 |
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 5th, 2022 |
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 12th, 2023 |
BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 20th, 2022 |
More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional) |
National Institutes of Health |
| August 31st, 2022 |
Tribal Self-Governance Planning Cooperative Agreement Program |
Indian Health Service |
| August 31st, 2022 |
Tribal Self-Governance Negotiation Cooperative Agreement Program |
Indian Health Service |
| September 19th, 2022 |
Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed) |
National Institutes of Health |
| January 13th, 2023 |
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| October 6th, 2022 |
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| October 6th, 2022 |
Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 6th, 2022 |
Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) |
National Institutes of Health |
| September 25th, 2025 |
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) |
National Institutes of Health |
| October 13th, 2022 |
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
| October 13th, 2022 |
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed) |
National Institutes of Health |
